Promising inhibitors, such as compound 974, PM01183, Zoledronic acid, ATRA, ALDHi 673A, and Limonin, have shown effectiveness in inhibiting ALDH1 activity, thereby reducing tumor proliferation and stemness in cervical cancer [56,113,114]. This evidence concerns the gene ALDH1A1 and cervical carcinoma.